Theravance Biopharma, Inc. (TBPH)
17.61
-0.20
(-1.12%)
USD |
NASDAQ |
Dec 10, 16:00
19.47
+1.86
(+10.56%)
After-Hours: 05:43
Theravance Biopharma Price: 17.61 for Dec. 10, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Perspective Therapeutics, Inc. | 2.55 |
| Skye Bioscience, Inc. | 1.14 |
| FibroGen, Inc. | 8.82 |
| Myomo, Inc. | 1.07 |
| VYNE Therapeutics, Inc. | 0.404 |
Price Related Metrics
| PE Ratio | 31.31 |
| PS Ratio | 11.05 |
| Price to Book Value | 3.835 |
| Price to Free Cash Flow | 3.646 |
| Earnings Yield | 3.19% |
| Market Cap | 892.34M |
| Normalized PE Ratio | 31.31 |